Skip to content

Net Income at other companies

Pfizer logo
PfizerPFE
$2.69B-9.4%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-$26.78M-62.5%
Philip Morris International logo
Philip Morris InternationalPM
$2.44B-9.4%

Other financials

Income statement

See full
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's net income?
Achieve Life Sciences (ACHV) reported net income of -$10.17M in Q1 2026.
How has Achieve Life Sciences's net income changed year-over-year?
Achieve Life Sciences's net income increased by 20.7% year-over-year, from -$12.83M to -$10.17M.
What is the long-term trend for Achieve Life Sciences's net income?
Over 4 years (2021 to 2025), Achieve Life Sciences's net income has grown at a 13.3% compound annual growth rate (CAGR), from -$33.15M to -$54.65M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.